It is with mixed emotions that I share with you the news that I have decided to transition to a new role in the All of Us Research Program of the National Institutes of Health. When a new leader has been selected, I will become the program’s chief innovation officer, driving the strategic and user-centered development of new program features. This will give me the opportunity to continue to bring in new methods and processes for innovation from my 25-year career in Silicon Valley.
As someone treated for cancer for 23 years and a transplantee, this will be an opportunity for me to focus on staying healthy over the long term and spend more time wearing my “patient advocate” hat, engaging directly with our participants and community partners. This change also represents the evolution of the program from a start-up to a more established organization with an emphasis on enhancing the All of Us experience for participants and researchers alike.
A nationwide search will begin this week for a new director/chief executive officer to lead the program into its next phase. I will continue to lead the program until a new director is appointed, and I will stay on as part of the leadership team in my new capacity.
I have loved being the “start-up CEO" of this program more than any job in my life, and I’m grateful to NIH Director Dr. Francis Collins for his support as we built the program and through this transition. I also want to acknowledge the talent, commitment, and camaraderie of the entire All of Us team and consortium, who have accomplished a tremendous deal in short order. I look forward to working with them as we continue the journey to revolutionize research and health into the future.
Eric Dishman
Director, All of Us Research Program, NIH
